Sirolimus Solution
Product Images NDC 72205-099

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Sirolimus (NDC 72205-099). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sirolimus-carton-label (Sirolimus Carton Label)

Sirolimus Oral Solution 1 mg/mL in a 60 mL package. The label indicates the product is for oral use only and is Rx only. It is manufactured by MSN Pharmaceuticals Inc. and distributed by Novadoz Pharmaceuticals LLC. The packaging includes storage instructions to refrigerate between 2°C to 8°C and protect from light. The label also advises use within one month after opening and contains a pharmacist dispensing notice.*

FDA Label Image

Sirolimus-container-label (Sirolimus Container Label)

Label for Sirolimus Oral Solution 1 mg/mL in a 60 mL container, a human prescription drug by Novadoz Pharmaceuticals LLC. The label includes usage instructions to store refrigerated at 2° to 8°C, protect from light, and use contents within one month after opening. It also states that the solution contains 1 mg sirolimus per mL along with ethanol, propylene glycol, soy lecithin, and polysorbate 80. Manufacturer is MSN Pharmaceuticals Inc., Piscataway, NJ.*

FDA Label Image

Sirolimus-fig-1 (Sirolimus Fig 1)

A line graph depicting sirolimus versus placebo effects on FEV1 (L) over a 24-month period. The chart shows two phases, treatment and observation, with sirolimus maintaining higher FEV1 values throughout. Subject counts for sirolimus and placebo groups at different months are listed below the graph.*

FDA Label Image

Sirolimus-instruction-fig-1 (Sirolimus Instruction Fig 1)

Instructional illustration showing a hand twisting open the child-resistant cap of a small bottle, demonstrating the proper method to open the oral solution container.*

FDA Label Image

Sirolimus-instruction-fig-2 (Sirolimus Instruction Fig 2)

Illustration showing a hand gripping a vial with an arrow pointing downward, possibly indicating the action of pressing or securing the vial's cap or stopper. No text or branding visible.*

FDA Label Image

Sirolimus-instruction-fig-3 (Sirolimus Instruction Fig 3)

An instructional illustration showing two steps of administering sirolimus oral solution. The first panel shows a hand pressing down a plunger on a syringe. The second panel depicts the same hand inserting the syringe into a bottle, pushing the plunger downward to withdraw the solution.*

FDA Label Image

Sirolimus-instruction-fig-4 (Sirolimus Instruction Fig 4)

An instructional illustration showing how to use a syringe to withdraw oral solution from a bottle. One hand holds the bottle while the other pulls the syringe plunger upward. A circular inset highlights the syringe measurement markings for accurate dosing.*

FDA Label Image

Sirolimus-instruction-fig-5 (Sirolimus Instruction Fig 5)

An instructional illustration showing a hand holding an oral syringe while the other hand removes a cap from it, indicating how to prepare the syringe for administering oral medication.*

FDA Label Image

Sirolimus-instructions-fig-6 (Sirolimus Instruction Fig 6)

An instructional illustration showing a hand holding a syringe above a tray that contains a calibration spoon or applicator. The image appears to demonstrate preparation or administration steps related to a medication dosage.*

FDA Label Image

Sirolimus-instruction-fig-7 (Sirolimus Instruction Fig 7)

An instructional illustration showing a syringe above a small clear cup filled with liquid, with an arrow pointing from the syringe tip toward the liquid in the cup, indicating a step in preparation or administration of an oral solution.*

FDA Label Image

Sirolimus-instruction-fig (Sirolimus Instruction Fig)

Illustration showing components of a sirolimus oral solution packaging set, including a bottle (a), a cap with attached tubing (b), two long measuring devices or syringes (c), and a rectangular storage box with lid (d). These parts appear to be intended for preparation or administration of the sirolimus oral solution.*

FDA Label Image

Sirolimus-kit-carton-label (Sirolimus Kit Carton Label)

Sirolimus Oral Solution 1 mg/mL carton from Novadoz Pharmaceuticals LLC. The label includes dosing and storage instructions, patient kit contents (60 mL amber bottle, oral syringe adapter, 30 amber oral syringes, caps, and carrying case), and handling instructions. It is a prescription oral solution with NDC 72205-099-78, emphasizing protection from light and refrigeration requirements.*

FDA Label Image

Sirolimus-structure (Sirolimus Structure)

Chemical structure diagram of sirolimus, illustrating the molecular arrangement of its atoms and bonds as seen in the product labeling.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.